Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Cardiovascular Diseases 1

Interventions

Carboplatin 106Cisplatin 97Paclitaxel 78pembrolizumab 69Gemcitabine 59Pemetrexed 49Cyclophosphamide 46Docetaxel 45Dexamethasone 45durvalumab 44Capecitabine 44Radiotherapy 40Nivolumab 37Lenalidomide 37Specimen Handling 36Doxorubicin 36Rituximab 34Oxaliplatin 34Bevacizumab 33Magnetic Resonance Spectroscopy 32Fluorouracil 32atezolizumab 29Etoposide 29Vincristine 26Radiation 26Leucovorin 26Letrozole 24Bortezomib 24Fulvestrant 23Prednisone 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Fatty Acids, Omega-3 × Clear all
NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting
25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡